Lacutamab

(Synonyms: IPH 4102; Anti-KIR3DL2/CD158k Reference Antibody (lacutamab))
Customer Review

Based on 1 Customer Validation

Lacutamab (IPH 4102) is a humanized monoclonal antibody targeting KIR3DL2/CD158k, which eliminates KIR3DL2-expressing cells via antibody-dependent cellular cytotoxicity and phagocytosis. Lacutamab is applicable to research related to mycosis fungoides, relapsed or refractory peripheral T-cell lymphoma, and relapsed or refractory cutaneous T-cell lymphoma.

For research use only. We do not sell to patients.

  • Purity: ≥99.0%
  • CAS No.: 2187368-16-5
  • Molecular Weight:144.52 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All MHC Isoforms

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00